Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: Investigations into possible mechanism of action in vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 3, 2000, Pages 800-809

  Bond, A ^a   Jones, N M ^a   Hicks, C A ^a   Whiffin, G M ^a   Ward, M A ^a   O'Neill, M F ^a   Kingston, A E ^a   Monn, J A ^a   Ornstein, P L ^a   Schoepp, D D ^a   Lodge, D ^a   O'Neill, M J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 2 (2 CARBOXYCYCLOPROPYL) 3 (XANTHEN 9 YL)PROPIONIC ACID; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; GERBIL; HIPPOCAMPUS; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY;

AMINO ACIDS; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN ISCHEMIA; BRAIN-DERIVED NEUROTROPHIC FACTOR; CAROTID ARTERY DISEASES; EXCITATORY AMINO ACID AGONISTS; GERBILLINAE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOTOR ACTIVITY; NERVE GROWTH FACTOR; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, METABOTROPIC GLUTAMATE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033842964     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Post-ischemic hyperactivity in the Mongolian gerbil correlates with loss of hippocampal neurons
2. In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats
3. Selective activation of group II mGluRs with LY354740 does not prevent neuronal excitotoxicity
4. NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus
5. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischemia
6. LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global cerebral ischaemia
7. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-β
8. Activation of class II or III metabotropic glutamate receptors protects caltured cortical neurons against excitotoxic degeneration
9. The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial neuronal signalling
10. The inhibitory mGluR agonist, S-4-carboxy-3-hydroxyphenylglycine selectivity attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death
11. DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons
12. Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia
13. Activation of metabotropic glutamate receptors protects neurons against apoptosis induced by β-amyloid peptide
14. Pharmacology of AMPA antagonists and their role in neuroprotection
15. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia
16. MK-801, but not anisomysin, inhibits the induction of tolerance to ischemia in the gerbil hippocampus
17. Presynaptic inhibitory action of the group II metabotropic glutamate receptor agonists, LY354740 and DCG-IV
18. Neuroprotection by metabotropic receptor agonists: LY354740, LY379268 and LY389795
19. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors
20. Delayed neuronal death in the gerbil hippocampus following ischemia
21. Induced tolerance to ischemia in gerbil hippocampal neurons
22. Effects of the selective metabotropic glutamate agonist, LY354740 in a rat model of permanent ischaemia
23. Stereoselective effects of 2,3-banzodiazepines in vivo: Electrophysiology and neuroprotection studies
24. Ischaemic brain damage: Prevention with competitive and non-competitive antagonists of N-methyl-D-aspartate receptors
25. Excitatory amino acids in neurotoxicity and neurodegenerative diseases
26. The use of locomotor activity as a behavioural screen for neuronal damage following transient forebrain ischemia in gerbils
27. Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat
28. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-amino[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors
29. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders?
30. Neuroprotection after several days of mild, drug-induced hypothermia
31. + channel inhibitors in vitro and in global cerebral ischaemia in vivo
32. Decahydroisoquinolines: Novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia
33. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations
34. New perspectives for the development of selective metabotropic glutamate receptor ligands
35. The metabotropic glutamate receptors: Structure and function
36. Metabotropic glutamate receptors in brain function and pathology
37. Pharmacological agents acting at sub-types of metabotropic glutamate receptors
38. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors
39. Differential presynaptic localization of metabotropic glutamate receptor subtypes, mGluR2/3 and mGluR7 in the hippocampus
40. Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors